Back
Speaker illustration

Professor Junichi Ishii

Fujita Health University Second Hospital, Nagoya (Japan)

Presentations

Circulating presepsin (soluble CD14 subtype) as a novel marker of mortality in patients treated at medical cardiac intensive care units

Event: ESC Congress 2020

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session: Cardiac ITU Is about the Heart, and More

Access
Like
Thumbnail

Circulating concentration of presepsin improves early prediction of short-term mortality in patients treated at medical cardiac intensive care units

Event: ESC Congress 2019

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session: Acute coronary syndrome no-reflow

Access
Like
Thumbnail

Combination of presepsin, soluble CD14 subtype, and B-type natriuretic peptide predicts six-month mortality in patients hospitalized for worsening heart failure

Event: ESC Congress 2018

Topic: Biomarkers

Session: "Biomarkers reloaded": Diagnosis and prognosis of acute heart failure

Access
Like
Thumbnail

Circulating presepsin (soluble CD14 subtype) as a novel marker of mortality in patients treated at medical cardiac intensive care units

Event: ESC Asia with APSC & AFC 2020

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session: Abstract Programme

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources